Arbutus Biopharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Arbutus Biopharma Corporation (ABUS) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.040.130.030.110.120.090.12
Short-Term Investments0.090.100.120.050.070.000.00
Cash & Short-Term Investments0.120.130.150.160.120.090.12
Accounts Receivable0.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.000.000.000.000.000.000.00
Total Current Assets0.130.130.150.160.130.090.13
Non-Current Assets
Property, Plant & Equipment (Net)0.000.010.010.010.010.010.01
Long-Term Investments0.000.010.040.040.000.000.00
Other Non-Current Assets0.000.000.000.000.000.000.00
Total Non-Current Assets0.000.010.040.040.010.010.10
Total Assets0.130.140.200.200.140.110.23
Current Liabilities
Accounts Payable0.000.010.000.000.010.010.01
Short-Term Debt0.000.000.000.000.000.000.00
Accrued Liabilities0.010.010.010.010.010.000.00
Deferred Revenue0.010.010.020.000.000.000.00
Other Current Liabilities0.010.010.000.000.000.000.00
Total Current Liabilities0.020.020.030.010.010.010.01
Non-Current Liabilities
Long-Term Debt0.000.000.010.000.000.000.00
Other Non-Current Liabilities0.020.010.010.020.000.000.00
Total Non-Current Liabilities0.020.020.030.020.030.030.02
Total Liabilities0.030.040.060.040.040.030.03
Stockholders' Equity
Common Stock1.411.351.321.290.990.000.00
Retained Earnings-1.35-1.33-1.20-1.13-1.09-1.02-0.81
Accumulated Other Comprehensive Income-0.05-0.05-0.05-0.05-0.05-0.05-0.05
Additional Paid-in Capital0.080.080.070.070.060.060.05
Shares Outstanding0.190.170.160.140.000.000.00
Total Stockholders' Equity0.100.110.140.170.100.070.20
Total Liabilities & Equity0.130.140.200.200.140.110.23